Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114213318A details a novel DES-based synthesis for dihydropyridines, offering high purity, solvent recyclability, and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed visible light method for SuFEx warheads. High purity pharmaceutical intermediates with scalable green chemistry processes.
Patent CN103553931A reveals a novel organocatalytic route for chiral diketones, delivering high enantioselectivity and yield for efficient steroid and terpenoid synthesis.
Patent CN109970789B reveals a metal-free route for triarylphosphine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN105949136A reveals metal-free triazole synthesis. Enhance pharmaceutical intermediate supply chain with reduced contamination risks and scalable organic catalysis.
Novel patent CN104098484A details efficient Iopamidol production. Reduces costs and improves supply chain reliability for contrast agent manufacturing.
Novel preparation method ensures high purity and safety. Ideal for reliable pharmaceutical intermediates supplier partnerships reducing manufacturing costs.
Patent CN106565805B reveals a cost-effective D-ribose route for Sofosbuvir, offering reliable supply chain solutions and reduced manufacturing complexity for global pharmaceutical buyers.
Patent CN119775259B details a novel resin-supported catalyst method for high-purity Amatinib intermediate production, offering significant supply chain and cost advantages.
Patent CN107987005A details blue LED photocatalysis for high-purity intermediates. This method ensures green chemistry compliance and significant cost reduction in pharmaceutical intermediates manufacturing supply chains.
Novel metal-free synthesis of naphthofurans offers significant cost reduction and enhanced supply reliability for pharmaceutical intermediate manufacturing partners seeking high purity materials globally.
Patent CN108503573B details a high-purity Brivaracetam route eliminating chiral separation. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN103347846A reveals a novel imidazoline salt catalyst for efficient alpha-hydroxyketone production, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110194735B details a visible light catalytic method for chiral amines. Offers high ee values and metal-free conditions for efficient API intermediate manufacturing.
Novel one-pot Ferrier rearrangement using FeCl3 catalyst. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114249690A reveals a novel DBU-catalyzed route for Roxadustat. Achieve high purity and reduced manufacturing costs with our scalable pharmaceutical intermediate solutions.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Novel synthesis route for methyl piperidinyl acetate intermediate offers high yield and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN114105972B reveals a novel cinchonine derivative boosting enantioselectivity to over 90 percent for indoxacarb synthesis, offering significant cost and supply chain advantages.
Patent CN112280755B reveals mutant enzyme technology for GHK tripeptide. Achieve high yield and purity with scalable enzymatic processes for cosmetic and pharma applications.